Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2024

May 2, 2024

29821_dirs_2024-05-02_261e831c-3960-431d-a3c4-cf380656d5b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2024-05-01

Reporting Person: Carruthers Wendy (EVP, Human Resources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-01 Common Stock M 3066.0000 $17.2600 Acquired 54134.0000 Direct
2024-05-01 Common Stock M 1197.0000 $24.5500 Acquired 55331.0000 Direct
2024-05-01 Common Stock S 6983.0000 $71.4700 Disposed 48348.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-01 Stock Option (Right to Buy) $17.2600 M 3066.0000 Disposed 2026-02-22 Common Stock (3066.0000) Direct
2024-05-01 Stock Option (Right to Buy) $24.5500 M 1197.0000 Disposed 2027-02-28 Common Stock (1197.0000) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.